1

West Pharmaceuticals reported strong first-quarter performance, with 13% organic sales growth and double-digit growth in adjusted earnings per share. The company's gross profit margin improved by 130 basis points, driven by growth in high-value products and production efficiencies. West's adjusted operating profit margin increased by 180 basis points, largely due to the expansion of its Proprietary Products' gross profit. The company's full-year 2020 net sales guidance remains in a range of between $1.95 billion and $1.97 billion, with an estimated headwind of $26 million based on current foreign exchange rates.